PEPTIDE INHIBITOR OF HSP90 Read more about PEPTIDE INHIBITOR OF HSP90 US Application 60/895,313Filed on 2007-03-16
Mesothelin Expression In Human Lung Cancer Read more about Mesothelin Expression In Human Lung Cancer US Application 60/891,923Filed on 2007-02-27
TNF-ALPHA BLOCKER TREATMENT FOR ENTEROCOLITIS ASSOCIATED WITH IMMUNOSTIMULATORY THERAPEUTIC ANTIBODY THERAPY Read more about TNF-ALPHA BLOCKER TREATMENT FOR ENTEROCOLITIS ASSOCIATED WITH IMMUNOSTIMULATORY THERAPEUTIC ANTIBODY THERAPY US Application 60/734,963Filed on 2005-11-08
Prophylaxis and treatment of entercolitis associated witih anti-CTLA-4 antibody therapy Read more about Prophylaxis and treatment of entercolitis associated witih anti-CTLA-4 antibody therapy US Application 60/734,881Filed on 2005-11-08
Novel Nanoparticles For Photodynamic Therapy And Biological/Clinical Imaging Applications Read more about Novel Nanoparticles For Photodynamic Therapy And Biological/Clinical Imaging Applications US Application 60/805,437Filed on 2006-06-21
Mutant Alleles Of HSP90 That Modulate The Lifespan Of Yeast (and Potentially Of Higher Organisms Including Humans) Read more about Mutant Alleles Of HSP90 That Modulate The Lifespan Of Yeast (and Potentially Of Higher Organisms Including Humans) US Application 60/848,346Filed on 2006-09-30
Improved DNA Vaccination Protocols Read more about Improved DNA Vaccination Protocols US Application 60/934,366Filed on 2007-06-12
Methods For Identifing Markers For Early-stage Human Cancer, Cancer Progression And Recurrence Read more about Methods For Identifing Markers For Early-stage Human Cancer, Cancer Progression And Recurrence US Application 60/722,594Filed on 2005-09-30
Papillomavirus L2 N-terminal Peptides For The Induction Of Broadly Cross-neutralizing Antibodies Read more about Papillomavirus L2 N-terminal Peptides For The Induction Of Broadly Cross-neutralizing Antibodies US Application 60/752,268Filed on 2005-12-21
Papillomavirus L2 N-terminal Peptides For The Induction Of Broadly Cross-neutralizing Antibodies Read more about Papillomavirus L2 N-terminal Peptides For The Induction Of Broadly Cross-neutralizing Antibodies US Application 60/697,655Filed on 2005-07-07